NASDAQ:SPPI
Delisted

Spectrum Pharmaceuticals Stock News

etoro logo Buy SPPI
*Your capital is at risk
$1.03
+0 (+0%)
At Close: Oct 30, 2023
NEW YORK, Sept. 2, 2021 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Spectrum Pharmaceuticals, Inc.
SAN DIEGO, Sept. 2, 2021 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that the Spectrum Pharmaceuticals class action lawsuit charges Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) and cer
Los Angeles, California--(Newsfile Corp. - September 2, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Spectrum Pharmac
NEW YORK, Sept. 1, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of investors who
LOS ANGELES--(BUSINESS WIRE)---- $SPPI #SPPI--SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc.
Boston, Massachusetts--(Newsfile Corp. - September 1, 2021) - Block & Leviton announces that a class action lawsuit has been filed against Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) for potential s
NEW YORK, Aug. 31, 2021 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Spectrum Pharmaceuticals, Inc ("Spectrum" or the "Company") (NASDAQ: SPPI) and certai
New York, New York--(Newsfile Corp. - August 17, 2021) -  Pomerantz LLP is investigating claims on behalf of investors of Spectrum Pharmaceuticals, Inc. ("Spectrum" or the "Company") (NASDAQ: SPPI).
Spectrum Pharmaceuticals, Inc. (SPPI) CEO Joe Turgeon on Q2 2021 Results - Earnings Call Transcript
HENDERSON, Nev.--(BUSINESS WIRE)---- $SPPI--Spectrum Pharmaceuticals (SPPI), a biopharma company focused on novel and targeted oncology therapies, reports results for 2Q2021 and a corp update.
NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Spectrum Pharmaceuticals, Inc. (“Spectrum” or
NEW YORK, Aug. 9, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Spectrum Pharmaceuticals, Inc. ("Spectrum" or the "Company") (NASDAQ: SPPI).  Such investor
SAN DIEGO, Aug. 6, 2021 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by Spectrum Pharmaceuticals, Inc. ("Spectru
Boston, Massachusetts--(Newsfile Corp. - August 6, 2021) - Block & Leviton is investigating Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) for potential securities law violations. Investors who have lo
BeyondSpring's Plinabulin: Upcoming PDUFA And Positioning In The CIN Space
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE